Parichita Mishra

Parichita Mishra

Auto-generated profile, based on publicly available information

Parichita Mishra

Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Bio-Design and Manufacturing
Verified
Journal Article
Open access
PDF file
PMParichita Mishra
Parichita Mishra
VBVidhi Manish Badiyani
Vidhi Manish Badiyani
ASAbhishek Kumar Singh
Abhishek Kumar Singh
VPVivek Pandey
Vivek Pandey
Manash K. PaulManash K. Paul
Manash K. Paul
BSBhisham Narayan Singh
Bhisham Narayan Singh
Osteoarthritis is a common aging-related disorder that is confined mostly to the chondral layer of joints (e.g., the knee) but can spread to bony layers over time. In its early stages, osteoarthritis has minimal symptoms; however, these gradually worsen over time and include joint pain, stiffness, loss of mobility, and inflammation. The exposed subchondral bone of a Grade 4 osteoarthritic knee is highly prone to erosion if left untreated due to persistent rubbing between the bones, which can lead to painful bone spurs. However, treating osteoarthritis is especially challenging due to the poor mitotic potential and low metabolic activity of chondrocytes. Although currently available tissue-engineered products (e.g., BST-CarGel®, TruFit®, and Atelocollagen®) can achieve structural reconstruction and tissue regeneration, final clinical outcomes can still be improved. Major challenges faced during clinical studies of tissue-engineered constructs include chondrocyte hypertrophy and the development of mechanically inferior fibrous tissue, among others. These issues can be addressed by selecting suitable biomaterial combinations, mimicking the three-dimensional (3D) architecture of the tissue matrix, and better controlling inflammation. Furthermore, it is crucial to generate essential signaling molecules within the articular cartilage ecosystem. This approach must also account for the microarchitecture of the affected joint and support the chondrogenic differentiation of mesenchymal stem cells. The use of tissue-engineered constructs has the potential to overcome each of these challenges, since materials can be modified for drug/biomolecule delivery while simultaneously facilitating the regeneration of robust articular cartilage. Three-dimensional printing has been successfully used in tissue engineering to achieve bioprinting. By manipulating conventional 3D printing techniques and the types of bioink used, many different types of bioprinting have emerged. Overall, these bioprinting techniques can be used to address various challenges associated with osteoarthritis treatment.

4 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SSSwathi Sadashiva
Swathi Sadashiva
PMParichita Mishra
Parichita Mishra
AMAnuj Mandrekar
Anuj Mandrekar
SBShyamasunder N Bhat
Shyamasunder N Bhat
SHShripad S. Hebbar
Shripad S. Hebbar
BSBhisham Narayan Singh
Bhisham Narayan Singh
Bone tissue possesses intrinsic capacity to repair noncritical defects; however, regeneration becomes challenging in non-union critical-sized long bone tissue defects. Thus, various types of resorbable grafts as an alternative to autografts were investigated to bridge the non-union gaps. However, the success of such grafts was limited due to its inability to mimic hierarchical bone tissue architecture with a cortical-cancellous gradient limiting proper bone ingrowth, improper vascularization and fails to integrate. Nevertheless, designing scaffolds that effectively mimic the hierarchical organization of cortical-cancellous bone tissue gradients remains a significant challenge. In the present study, a biomimetic computer-aided design (CAD) inspired by leaf venation patterns was developed to establish a hierarchical architecture resembling the transition of cortical to cancellous bone layers in a 3D-printed scaffold. Polycaprolactone (PCL) with various amounts (2.5 - 20% w/v) of hydroxyapatite (HAP) based composite inks were printed with two different needle gauges (22G & 25G), and the resulting scaffolds were systematically characterized for pore size, filament thickness, and mechanical properties to identify the optimal design. To further mimic the native extracellular matrix, gelatin was incorporated as a ground substance within the PCL/HAP skeletal framework. Notably, printed scaffold architecture plays significantly role in establishment of hierarchical pore size gradient across the gelatin phase (Zone B-306 ± 60 µm to Zone E-101 ± 33 µm). Further, in-vitro studies were performed to validate improved cell adhesion, proliferation, and osteogenic differentiation. These findings highlight the potential of biomimetic hierarchical scaffold design combined with ground substance incorporation for bone tissue engineering applications.